Efficacy and safety of eptastigmine for the treatment of patients with Alzheimer's disease.

Imbimbo, B P; Martelli, P; Troetel, W M; Lucchelli, F; Lucca, U; Thal, L J

Imbimbo, B P; Martelli, P; Troetel, W M; Lucchelli, F; Lucca, U; Thal, L J.

Affiliation

Imbimbo BP; Medical Department, Mediolanum Farmaceutici, Milan, Italy.

Neurology ; 52(4): 700-8, 1999 Mar 10.

Article in En | MEDLINE | ID: mdl-10078713

Subject(s)

Alzheimer Disease/drug therapy; Cholinesterase Inhibitors/adverse effects; Cholinesterase Inhibitors/therapeutic use; Physostigmine/analogs & derivatives; Aged; Aged, 80 and over; Cholinesterase Inhibitors/administration & dosage; Double-Blind Method; Female; Humans; Male; Middle Aged; Physostigmine/administration & dosage; Physostigmine/adverse effects; Physostigmine/therapeutic use; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Physostigmine / Cholinesterase Inhibitors / Alzheimer Disease Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Neurology Year: 1999 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links